Peptide Targeted by Human Antibodies Associated with HIV Vaccine-Associated Protection Assumes a Dynamic α-Helical Structure

The only evidence of vaccine-induced protection from HIV acquisition in humans was obtained in the RV144 HIV vaccine clinical trial. One immune correlate of risk in RV144 was observed to be higher titers of vaccine-induced antibodies (Abs) reacting with a 23-mer non-glycosylated peptide with the sam...

Descripción completa

Detalles Bibliográficos
Autores principales: Aiyegbo, Mohammed S., Shmelkov, Evgeny, Dominguez, Lorenzo, Goger, Michael, Battacharya, Shibani, deCamp, Allan C., Gilbert, Peter B., Berman, Phillip W., Cardozo, Timothy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5249078/
https://www.ncbi.nlm.nih.gov/pubmed/28107435
http://dx.doi.org/10.1371/journal.pone.0170530

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5249078/
https://www.ncbi.nlm.nih.gov/pubmed/28107435
http://dx.doi.org/10.1371/journal.pone.0170530

Ejemplares similares